U.S. markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
38.39-0.95 (-2.41%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close39.34
Bid38.39 x 1400
Ask39.60 x 3000
Day's Range38.37 - 38.70
52 Week Range33.26 - 42.68
Avg. Volume3,562,520
Market Cap96.584B
Beta (5Y Monthly)0.38
PE Ratio (TTM)16.12
EPS (TTM)2.38
Earnings DateFeb 01, 2017 - Feb 06, 2017
Forward Dividend & Yield2.21 (5.76%)
Ex-Dividend DateAug 19, 2021
1y Target Est48.21
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-11% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GlaxoSmithKline PLC
    Analyst Report: GlaxoSmithKline plcIn the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
    Fair Value
    Economic Moat
    13 days agoMorningstar
View more